Sulfonyl compounds as inhibitors of 11-beta-hydroxysteroid dehydro- genase-1
Details for Australian Patent Application No. 2005271527 (hide)
International Classifications
Event Publications
22 February 2007 PCT application entered the National Phase
PCT publication WO2006/017542 Priority application(s): WO2006/017542
27 August 2009 Application Accepted
Published as AU-B-2005271527
24 December 2009 Standard Patent Sealed
21 January 2010 Amendment Made
The nature of the amendment is: Amend the Patentee from Merck & Co., Inc. to Merck Sharp & Dohme Corp.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser